Hematologic parameters are not predictors of upgrading or treatment in a racially diverse prospective study of men with prostate cancer on active surveillance.

Shelton, T Maxwell; Greenberg, Jacob W; Silberstein, Jonathan L; Krane, L Spencer

Shelton, T Maxwell; Greenberg, Jacob W; Silberstein, Jonathan L; Krane, L Spencer.

Afiliação

Shelton TM; Department of Urology, Tulane University School of Medicine, New Orleans, LA, USA.
Greenberg JW; Department of Urology, Tulane University School of Medicine, New Orleans, LA, USA.
Silberstein JL; Department of Urology, Tulane University School of Medicine, New Orleans, LA, USA.
Krane LS; Department of Urology, Tulane University School of Medicine, New Orleans, LA, USA.

Aging Male ; 23(5): 1400-1408, 2020 Dec.

Article em En | MEDLINE | ID: mdl-32500781

Assuntos

Neoplasias da Próstata; Conduta Expectante; Humanos; Linfócitos; Masculino; Prognóstico; Estudos Prospectivos; Estudos Retrospectivos

Palavras-chave

Active Surveillance; NLR; Neutrophil-to-lymphocyte ratio; PLR; Platelet-to-lymphocyte ratio; Prostate Cancer; Treatment Survival; Upgrading Survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Prostata Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Conduta Expectante Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans / Male Idioma: En Revista: Aging Male Assunto da revista: GERIATRIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google